Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0L4WO
|
||||
| Former ID |
DPR000186
|
||||
| Drug Name |
SGN-19A
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Hematologic malignancies [ICD9: 200-209; ICD10:C81-C86] | Preclinical | [551669] | ||
| Company |
Seattle Genetics
|
||||
| Target and Pathway | |||||
| Target(s) | B-lymphocyte antigen CD19 | Target Info | [551669] | ||
| NetPath Pathway | IL-7 Signaling Pathway | ||||
| PANTHER Pathway | B cell activation | ||||
| Pathway Interaction Database | BCR signaling pathway | ||||
| References | |||||